CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale SVP & Chief Commercial Officer sold 6,192 shares at $13.83 ($85,635)
- 4 Open-market sale SVP, COO & CFO sold 10,867 shares at an average $13.76 ($149,481)
- 4 Open-market sale Director sold 5,721 shares at an average $16.81 ($96,148)
- 4 Open-market sale Chief R&D Officer sold 31,111 shares at $18.30 ($569,331)
- 4 Open-market sale SVP & General Counsel sold 1,917 shares at $18.30 ($35,081)
- 4 Open-market sale SVP & Chief Accounting Officer sold 13,391 shares at $18.30 ($245,055)
- 4 Open-market sale President & CEO sold 11,560 shares at $18.30 ($211,548)
- 4 Open-market sale SVP & Chief Commercial Officer sold 6,085 shares at $18.30 ($111,356)
- 4 Open-market sale SVP, COO & CFO sold 7,898 shares at $18.30 ($144,533)
- 4 Open-market sale Director sold 8,000 shares at $19.34 ($154,720)
- 4 Open-market sale Director sold 8,000 shares at $18.98 ($151,840)
- 4 Open-market sale Chief R&D Officer sold 24,141 shares at $22.37 ($540,034)
- 4 Open-market sale SVP & General Counsel sold 2,173 shares at $22.37 ($48,610)
- 4 Open-market sale SVP & Chief Accounting Officer sold 11,705 shares at $22.37 ($261,841)
- 4 Open-market sale President & CEO sold 11,495 shares at $22.37 ($257,143)
- 4 Open-market sale SVP & Chief Commercial Officer sold 15,358 shares at $22.37 ($343,558)
- 4 Open-market sale SVP, COO & CFO sold 7,977 shares at $22.37 ($178,445)
- 4 Open-market sale SVP & General Counsel sold 5,344 shares at $19.45 ($103,941)
- 4 Open-market sale President & CEO sold 450,000 shares at an average $19.93 ($8,966,931)
- 4 Open-market sale SVP, COO & CFO sold 150,000 shares at an average $19.86 ($2,979,629)
Page 9 of 49 · 968 filings